Meropenem (in combination with amikacin) was used in the treatment of children and adolescents with mucoviscidosis and severe exacerbation of bronchopulmonary affections. The drug showed satisfactory clinical and moderate bacteriological effects (48.3%) as dependent on the severity and duration of the disease and the microbial flora. Meropenem was well tolerated: no side effects were observed during the treatment, whereas it was used in high doses (60-105 mg/kg daily).
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Protectin DX Relieve Hyperoxia-induced Lung Injury by Protecting Pulmonary Endothelial Glycocalyx.
J Inflamm Res
February 2023
Department of Anesthesia and Critical Care, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Zhejiang, People's Republic of China.
Background: Bronchopulmonary dysplasia (BPD) is a common chronic lung disease in premature infants with limited treatments and poor prognosis. Damaged endothelial glycocalyx leads to vascular permeability, lung edema and inflammation. However, whether hyperoxia increases neonatal pulmonary microvascular permeability by degrading the endothelial glycocalyx remains unknown.
View Article and Find Full Text PDF[The characteristics of medical demographic indices in the Jewish autonomous oblast].
Probl Sotsialnoi Gig Zdravookhranenniiai Istor Med
January 2022
The Federal State Budget Educational Institution of Higher Education "The Far-Eastern State Medical University" of Minzdrav of Russia, 680000, Khabarovsk, Russia.
The research in the field of regional trends and risk factors related to population morbidity is considered as background of management decision-making in health care. The article presents the results of analysis of medical demographic indices and population health status in the Jewish Autonomous Oblast in 2000-2019. It is established that in in the Jewish Autonomous Oblast population size reduced by 35 100 people to 2019.
View Article and Find Full Text PDF[Aspergillus-related respiratory conditions and COPD: Diagnostic challenges].
Rev Mal Respir
April 2020
Service de pneumologie, université Paris Descartes, groupe hospitalier Cochin, AP-HP, 27, rue du Faubourg-Saint-Jacques, 75014 Paris, France. Electronic address:
Introduction: The relations between chronic obstructive pulmonary disease (COPD) and respiratory diseases due to Aspergillus spp. are not well understood.
Methods: We analysed a retrospective series of patients hospitalized with a diagnosis of COPD and respiratory disease due to Aspergillus.
Bronchopulmonary and vascular anomalies are frequent in children with oesophageal atresia.
Acta Paediatr
June 2020
Pediatric Pulmonology and Allergy Department, Pole Enfant, Jeanne de Flandre Hospital, CHU Lille, Univ. Lille, Lille, France.
Article Synopsis
- The study aimed to investigate intrathoracic abnormalities in children with oesophageal atresia using computed tomography (CT).
- Researchers reviewed CT scans of 48 out of 234 patients, discovering several unexpected thoracic malformations and confirming known issues.
- The findings suggest that these intrathoracic anomalies are common in patients with oesophageal atresia, highlighting the importance of using contrast-enhanced chest CT for those with ongoing respiratory issues.
Pulmonary vascular disease is evident in gene regulation of experimental bronchopulmonary dysplasia.
J Matern Fetal Neonatal Med
June 2020
Department of Pediatric Research, University of Oslo, Oslo, Norway.
To examine the gene expression regarding pulmonary vascular disease in experimental bronchopulmonary dysplasia in young mice. Premature delivery puts babies at risk of severe complications. Bronchopulmonary dysplasia (BPD) is a common complication of premature birth leading to lifelong affection of pulmonary function.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!